The "super mutant" of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition

Carlos Huerta, Nick V. Grishin, Hong Zhang

Research output: Contribution to journalArticle

Abstract

FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.

Original languageEnglish (US)
Pages (from-to)3615-3617
Number of pages3
JournalBiochemistry
Volume52
Issue number21
DOIs
StatePublished - May 28 2013

Fingerprint

FMN adenylyltransferase
Yeast
Byproducts
Flavin-Adenine Dinucleotide
Riboflavin
Yeasts
Enzymes
Mutagenesis
Kinetics

ASJC Scopus subject areas

  • Biochemistry

Cite this

The "super mutant" of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition. / Huerta, Carlos; Grishin, Nick V.; Zhang, Hong.

In: Biochemistry, Vol. 52, No. 21, 28.05.2013, p. 3615-3617.

Research output: Contribution to journalArticle

@article{d00979b37a0c4e49ba32bb8e4ef2b474,
title = "The {"}super mutant{"} of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition",
abstract = "FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.",
author = "Carlos Huerta and Grishin, {Nick V.} and Hong Zhang",
year = "2013",
month = "5",
day = "28",
doi = "10.1021/bi400454w",
language = "English (US)",
volume = "52",
pages = "3615--3617",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "21",

}

TY - JOUR

T1 - The "super mutant" of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition

AU - Huerta, Carlos

AU - Grishin, Nick V.

AU - Zhang, Hong

PY - 2013/5/28

Y1 - 2013/5/28

N2 - FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.

AB - FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.

UR - http://www.scopus.com/inward/record.url?scp=84878339896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878339896&partnerID=8YFLogxK

U2 - 10.1021/bi400454w

DO - 10.1021/bi400454w

M3 - Article

C2 - 23663086

AN - SCOPUS:84878339896

VL - 52

SP - 3615

EP - 3617

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 21

ER -